IMAX Corp. (IMAX) Misses Q1 EPS by 34c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pre-Open Movers 04/28: (IBIO) (RTIX) (FFIV) Higher; (NBES) (HLIT) (GAIA) Lower (more...)
April 28, 2020 9:27 AM EDTToday's Pre-Open Stock Movers
iBio, Inc. (NYSE: IBIO) 50% HIGHER; provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), one of 14 institutes in the Manufacturing USA Network.
RTI Surgical Holdings, Inc. (Nasdaq: RTIX) 29.9% HIGHER; announces a second amendment to its definitive agreement for the sale of RTI Surgical Holdings' OEM business to Montagu Private Equity LLP. Reduces the cash purchase price from $480,000,000 to... More
Benchmark Upgrades IMAX Corporation (IMAX) to Buy; Optimistic on Long-Term
April 28, 2020 5:59 AM EDT(Updated - April 28, 2020 8:12 AM EDT)
(updated to add analyst comments)
Benchmark analyst Mike Hickey upgraded IMAX Corporation (NYSE: IMAX) from Hold to Buy with a $14 price target.
The analyst commented, "We are upgrading IMAX to Buy with a $14 price target. We are optimistic that over... More
